Dewmar International BMC, Inc. (DEWM) CEO Dr. Marco Moran

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
45
Dewmar International BMC, Inc. (DEWM) CEO Dr. Marco Moran Appointed to Louisiana State University's College of Science Executive Committee

NEW ORLEANS, LA--(Marketwired - Aug 25, 2017) - Dewmar International BMC, Inc. (the "Company") ( OTC PINK : DEWM ) today announced that its CEO, Dr. Marco Moran , has been appointed to the Executive Committee within the College of Science at Louisiana State University .

The appointment is by special invitation of select members chosen from the College of Science Dean's Circle . The term of the appointment is for six (6) years.

The committee meets at least twice a year to vote on a series of annual awards, review policies and procedures, and to discuss the financial conditions with suggestions for improvement within the College of Science.

Dr. Moran had a recent interview featured in the Fall 2017 issue of the College of Science's magazine, The Pursuit , as one of the LSU 100 Honorees for 2016. Dewmar International has been a recipient of the LSU 100 Award for three of the past four years due to year over year business growth in revenue spanning over a 3-year period.

"We support the outstanding work of the members of our college community inclusive of our alumni and supporters," says Dr. Cynthia Peterson, Dean of the College of Science . "We are proud to have Dr. Moran as one of our most active members who also participated in a uniquely exclusive focus group, led by Zehno Cross Media Communications , as part of our marketing communications initiative where our stakeholders gathered insights about the college's strengths and identified opportunities to attract and connect more effectively with prospects, enhance national reputation, recruit top faculty, increase philanthropic giving, and optimize industrial partnerships. Dr. Moran's expertise and input was invaluable," Dr. Peterson continued.

Dr. Moran is scheduled to participate in a host of College of Science events planned for this fall inclusive of the Geaux Science Block Party on Thursday, September 7th. Dr. Moran will also attend a Fall Executive Committee meeting which is scheduled for Friday, October 13th inclusive of a field trip. The Dean's Circle Dinner will be that same evening at 5:30pm at the Hilton Baton Rouge Capitol Center.

"I have been a proud supporter of LSU for multiple years from sponsoring alumni college reunion events, attending football games, and serving academically via the Dean's Circle where fellow members and I provide working capital needed to fund many pursuits of the college including student organizations, educational travel expenses, faculty recruitment and alumni relations development initiatives to say the least," says Dr. Moran. "The College of Science is the most successful academic program within the University in raising capital to advance its initiative such as increasing diversity through minority and female recruitment in Science which I greatly appreciate," Dr. Moran continued.

Dewmar International has had discussions with various Colleges and Divisions at LSU regarding a series of cooperative efforts as it relates to technology transfer that includes conversations with Dr. Peterson and Andrew Maas with LSU Innovation regarding establishing a special microbiology laboratory within the College of Science for the development of an innovative microbe that significantly increases plant yield that can be partnered with the LSU College of Agriculture .

Additionally, Dr. Moran met with Dr. Brian Shedd with the College of Engineering and Dr. Robert Brown regarding the technical transfer of a number of patents held by the Bio-Life Science Department. Dewmar is reviewing a host of perspective projects proposed with a number of other LSU faculty & staff. Details of selected projects will be timely announced.

About Dewmar International BMC, Inc.

Dewmar International BMC, Inc. is a Louisiana certified service-disabled veteran-owned business concern, new product development, manufacturing and brand management company. Established in 2003, Dewmar's primary business strategy has been in creating high profit margins with functional foods and beverages, such as Lean Slow Motion Potion ; the longest placement period of all relaxation beverages in Walmart's history and Kush Cakes ; the top selling relaxation brownie in the U.S. market. The company has offices in Clinton, MS; Houston, TX; Denver, CO and New Orleans, LA. Dewmar was rated by the Mississippi Business Journal  as one of the State's top 15 publicly traded companies.

Follow and like Dewmar on its official Facebook and Twitter sites where the CEO is inclined to provide information, sometimes on a daily basis, about some of the Company's current activities. Also, subscribe to our Company Newsletter on the bottom right of our homepage to receive updates.

Click here for the Safe Harbor Statement. 

Dewmar International BMC, Inc. Investment & Company Information InvestorRelations@DewmarInternational.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Class Action Greenlighted Against Concordia for Title IX Violations

Updated Category News Views 87

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 104

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 149

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 118

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 202

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 162

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 179

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Maritime Safety Urged After New Orleans Vessel Incident

Updated Category News Views 109

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 145

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading

Top 5 Most Recently Viewed Articles

Kimbell Royalty Partners Engages Investors at Key Conferences

Updated Category News Views 101

Kimbell Royalty Partners to Attend Notable Investor Conferences Kimbell Royalty Partners, LP (NYSE: KRP) is a prominent owner of oil and natural gas mineral and royalty interests. The company proudly manages over 129,000 gross wells across multiple states. In an effort to strengthen investor relations and share its strategic outlook, Kimbell has announced its...

Continue Reading
Karsan's Autonomous Bus Debuts at Efteling Park

Updated Category News Views 72

A Leap Towards Autonomous Mobility What we have here is Karsan breaking new ground again. They've rolled out their Autonomous e-ATAK at Efteling, the famous theme park in the Netherlands. And that's not just any park—it's a place teeming with tourists, a hotspot demanding efficient transport. Yet, these folks aren't just cranking out fancy gadgets for showing off....

Continue Reading
EyePoint Pharmaceuticals Expands Workforce with Stock Options

Updated Category News Views 301

EyePoint Pharmaceuticals Expands Workforce with Stock Options EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a dynamic biopharmaceutical company, is on a mission to enhance the lives of patients facing serious retinal diseases. Recently, the company made a notable announcement regarding the expansion of its team through the granting of non-statutory stock options to new...

Continue Reading
IonQ Shares: Insights Into Their Current Market Performance

Updated Category News Views 204

Overview of IonQ's Current Stock Performance IonQ Inc. IONQ shares have seen a notable decline recently, continuing a downward trend that’s persisted over the last couple of weeks. As the company gears up to announce its second-quarter earnings, investors are closely monitoring the developments, particularly the anticipated shift in stock momentum. Market Sentiment and...

Continue Reading
Exploring the Promising CD47 Inhibitor Drug Market Growth

Updated Category News Views 40

Understanding the CD47 Inhibitor Drug Market Gaining insights into the CD47 inhibitor drug market is crucial for recognizing the changes and advancements in cancer immunotherapy. These drugs play a vital role in the battle against cancer by harnessing the body's immune system to identify and eliminate malignant cells. CD47's Role in Cancer CD47, often referred to as the...

Continue Reading